Covered recipient · General Payments record
ANDREA COFFEY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$942.41
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.21 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $286.31 | 22 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.77 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $24.30 | 1 |
| RedHill Biopharma Inc. | $19.77 | 1 |
| Merck Sharp & Dohme Corporation | $17.04 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.01 | 1 |
| Lilly USA, LLC | $15.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.01 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932671 | CMS |
| ABBVIE INC. | $19.11 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932673 | CMS |
| ABBVIE INC. | $19.25 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932675 | CMS |
| ABBVIE INC. | $2.43 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932677 | CMS |
| ABBVIE INC. | $10.29 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932679 | CMS |
| ABBVIE INC. | $19.83 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932681 | CMS |
| ABBVIE INC. | $6.50 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932683 | CMS |
| ABBVIE INC. | $17.30 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932685 | CMS |
| ABBVIE INC. | $6.75 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932687 | CMS |
| ABBVIE INC. | $25.63 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932689 | CMS |
| ABBVIE INC. | $28.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932691 | CMS |
| ABBVIE INC. | $8.18 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932693 | CMS |
| ABBVIE INC. | $8.26 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932695 | CMS |
| ABBVIE INC. | $6.71 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932697 | CMS |
| ABBVIE INC. | $19.12 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932699 | CMS |
| ABBVIE INC. | $7.49 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932701 | CMS |
| ABBVIE INC. | $17.18 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932703 | CMS |
| ABBVIE INC. | $7.12 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932705 | CMS |
| ABBVIE INC. | $17.13 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932707 | CMS |
| ABBVIE INC. | $6.79 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932709 | CMS |
| ABBVIE INC. | $6.86 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932711 | CMS |
| ABBVIE INC. | $20.37 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106932713 | CMS |
| Boston Scientific Corporation | $24.30 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092706980 | CMS |
| Lilly USA, LLC | $15.01 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135447273 | CMS |
| Merck Sharp & Dohme LLC | $17.04 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141834415 | CMS |
| RedHill Biopharma Inc. | $19.77 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095478725 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.01 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153593415 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.77 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137727214 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.